Lupin Digital Health CEO Sidharth Srinivasan Explores the Transformative Impact of Digital Therapeutics

Written By :  Dr. Nandita Mohan
Written By :  Sidharth Srinivasan
Published On 2024-03-09 15:53 GMT   |   Update On 2024-04-10 08:46 GMT

India Live 2024 , the paramount global cardiology event hosted by the Interventional Cardiology Foundation of India, focused on Interventional Cardiology: enabling quality outcomes for heart disease patients.Amidst this backdrop, Lupin Digital Health and the American College of Cardiology (ACC) announced a pioneering collaboration to introduce Digital Therapeutics (DTx) in India, aimed...

Login or Register to read the full article

India Live 2024 , the paramount global cardiology event hosted by the Interventional Cardiology Foundation of India, focused on Interventional Cardiology: enabling quality outcomes for heart disease patients.

Amidst this backdrop, Lupin Digital Health and the American College of Cardiology (ACC) announced a pioneering collaboration to introduce Digital Therapeutics (DTx) in India, aimed at delivering in-home cardiovascular care.
Their flagship product, Lyfe, launched just a year ago, represents a groundbreaking digital therapeutic solution designed to monitor and manage acute coronary syndrome (ACS) patients using advanced technologies.
In our conversation, with Mr. Sidharth Srinivasan, CEO of Lupin Digital Health, share insights on the transformative power of digital therapeutics. He discussed how Lupin Digital Health revolutionized healthcare in India by leveraging DTx and Remote Patient Monitoring to improve outcomes and reduce rehospitalization rates and explored the potential and challenges of digital therapeutics in reshaping cardiac care in India.


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News